The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes

We have identified genes differentially expressed in childhood early B acute lymphoblastic leukemia at diagnosis, according to chemosensitivity. Chemosensitive (M1) and chemoresistant (M3) patients present 25% of residual leukemic blasts at 21 days of treatment, respectively. The expression profiles...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Leukemia research 2006-06, Vol.30 (6), p.665-676
Hauptverfasser: Talby, Leila, Chambost, Hervé, Roubaud, Marie-Christine, N’Guyen, Catherine, Milili, Michèle, Loriod, Béatrice, Fossat, Chantal, Picard, Christophe, Gabert, Jean, Chiappetta, Pierre, Michel, Gérard, Schiff, Claudine
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!